Recent Updates
Recently added Catalysts
ZLAB

Zai Lab Announces Participation in January Investor Conferences – Zai Lab Limited

Key Takeaway: Zai Lab Announces Participation in January Investor Conferences – Zai Lab Limited
Price reaction · baseline $30.07 (2022-12-19 close) · hit after-hours · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close
+0.8%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer

Full Press Release Details

Zai Lab Announces Participation in January Investor Conferences – Zai Lab Limited.
Last updated: Dec 20, 2022